Business Description
Sichuan Kelun Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000PW7
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.28 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 1.22 | |||||
Interest Coverage | 14.47 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 4.34 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.5 | |||||
3-Year EBITDA Growth Rate | 21.7 | |||||
3-Year EPS without NRI Growth Rate | 51.5 | |||||
3-Year FCF Growth Rate | 49.5 | |||||
3-Year Book Growth Rate | 11.8 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 84.71 | |||||
9-Day RSI | 74.39 | |||||
14-Day RSI | 69.05 | |||||
6-1 Month Momentum % | 14.28 | |||||
12-1 Month Momentum % | -2.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.98 | |||||
Quick Ratio | 1.62 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 117.45 | |||||
Days Sales Outstanding | 85.81 | |||||
Days Payable | 81.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.9 | |||||
Dividend Payout Ratio | 0.34 | |||||
3-Year Dividend Growth Rate | 13.2 | |||||
Forward Dividend Yield % | 1.9 | |||||
5-Year Yield-on-Cost % | 5.55 | |||||
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | 8.06 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.8 | |||||
Operating Margin % | 18.66 | |||||
Net Margin % | 12.11 | |||||
FCF Margin % | 14.19 | |||||
ROE % | 14.22 | |||||
ROA % | 7.37 | |||||
ROIC % | 12.12 | |||||
ROC (Joel Greenblatt) % | 29.11 | |||||
ROCE % | 17.27 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.72 | |||||
PE Ratio without NRI | 17.76 | |||||
Shiller PE Ratio | 37.56 | |||||
Price-to-Owner-Earnings | 27.28 | |||||
PEG Ratio | 1.87 | |||||
PS Ratio | 2.27 | |||||
PB Ratio | 2.33 | |||||
Price-to-Tangible-Book | 2.48 | |||||
Price-to-Free-Cash-Flow | 15.97 | |||||
Price-to-Operating-Cash-Flow | 9.78 | |||||
EV-to-EBIT | 11.12 | |||||
EV-to-EBITDA | 11.12 | |||||
EV-to-Revenue | 2.21 | |||||
EV-to-FCF | 15.55 | |||||
Price-to-Projected-FCF | 1.22 | |||||
Price-to-DCF (Earnings Based) | 1.19 | |||||
Price-to-DCF (FCF Based) | 0.51 | |||||
Price-to-Median-PS-Value | 0.95 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.96 | |||||
Price-to-Graham-Number | 1.4 | |||||
Price-to-Net-Current-Asset-Value | 13.67 | |||||
Earnings Yield (Greenblatt) % | 8.99 | |||||
FCF Yield % | 6.03 | |||||
Forward Rate of Return (Yacktman) % | 22.58 |